ArticleiScience2022
Lipid flippase dysfunction as a therapeutic target for endosomal anomalies in Alzheimer's disease.
Nanaka Kaneshiro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ArticleiScience2022
Nanaka Kaneshiro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.